Roswell Biotechnologies Revenue and Competitors

Location

$37M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Roswell Biotechnologies's estimated annual revenue is currently $2.4M per year.(i)
  • Roswell Biotechnologies's estimated revenue per employee is $77,500
  • Roswell Biotechnologies's total funding is $37M.

Employee Data

  • Roswell Biotechnologies has 31 Employees.(i)
  • Roswell Biotechnologies grew their employee count by -6% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$1.1M70%N/AN/A
#4
$2.3M15150%N/AN/A
#5
$1.4M90%N/AN/A
#6
$11.5M74-12%N/AN/A
#7
$0.4M27510%$236.7MN/A
#8
$4M51-74%$160MN/A
#9
$2.5M1633%N/AN/A
#10
$3.3M21-12%N/AN/A
Add Company

Roswell Biotechnologies is a molecular electronics company transforming DNA sequencing with their new molecular electronics sequencing platform designed to deliver the disruptive performance required for future biomedical and industrial applications. The platform technology, ENDSeqᅢᄁ¬ダᅡᄁ (Electronic Nano-Device Sequencing), deploys single molecule sensor nanotechnology in a scalable semiconductor chip format, to deliver a dramatic reduction in the cost of genome-sequencing with unprecedented speed, accuracy and simplicity. Roswell is focused on delivering the molecular electronics chip and system that provides a $100, 1-hour whole human genome for use in precision medicine.

keywords:N/A

$37M

Total Funding

31

Number of Employees

$2.4M

Revenue (est)

-6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Roswell Biotechnologies News

2022-03-30 - This startup wants to make electronics out of single molecules

Twenty years after the field underwent a dramatic hype cycle, Roswell Biotechnologies is using single molecules to make better biosensor...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.6M31N/AN/A
#2
$3.6M31N/AN/A
#3
$3.6M31N/AN/A
#4
$6M310%N/A
#5
$6.7M31-9%N/A